Form 4: Foghorn Therapeutics Director Simba Gill Acquires 25,000 Stock Options
Insider Transaction Report
Foghorn Therapeutics Inc. Director Simba Gill reported the acquisition of 25,000 stock options with an exercise price of $4.79, exercisable from June 17, 2026, and expiring in 2035.
Summary
- Simba Gill, a Director of Foghorn Therapeutics Inc. (FHTX), acquired 25,000 stock options.
- The transaction date for this acquisition was June 17, 2025.
- The exercise price for these stock options is set at $4.79 per share.
- These options will become exercisable on June 17, 2026.
- The expiration date for these stock options is June 16, 2035.
- Following this reported transaction, Mr. Gill beneficially owns 25,000 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The acquisition of stock options by a director generally indicates a positive alignment of interests and potential confidence in the company's future stock performance, as the options' value is tied to the stock price exceeding the exercise price.
Positives
- The acquisition of stock options by a director can be interpreted as a positive signal, indicating management's confidence in the company's future performance and potential alignment of interests with shareholders.
- The defined exercise price of $4.79 provides a clear benchmark for the stock's future performance relative to the option's potential value.
Related Party Transactions
- Director Simba Gill's acquisition of 25,000 stock options from Foghorn Therapeutics Inc. constitutes a related party transaction, as it involves an insider receiving equity compensation from the company.
Stakeholder Impact
- Shareholders: The acquisition of stock options by a director can be viewed as a positive signal of management's confidence in the company's future, potentially aligning insider interests with shareholder value creation. However, the future exercise of these options could lead to minor share dilution.
Key Dates
| Date | Description |
|---|---|
| 06/17/2025 | Date of earliest transaction (acquisition of stock options) and signature date of the filing. |
| 06/17/2026 | Date when the acquired stock options become exercisable. |
| 06/16/2035 | Expiration date of the acquired stock options. |
Keywords
Foghorn Therapeutics, FHTX, Simba Gill, Director, Stock Options, Insider Trading, SEC Form 4, Beneficial Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.